These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 28650082)
1. Circulating high mobility group AT-hook 2 and pleomorphic adenoma gene 1 in blood of patients with oral squamous cell carcinoma. Ren W; Gao L; Li F; Qiang C; Li S; Zheng J; Kong X; Deng J; Cai G; Zhang H; Zhou M; Zhi K J Oral Pathol Med; 2017 Nov; 46(10):998-1003. PubMed ID: 28650082 [TBL] [Abstract][Full Text] [Related]
2. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma. Jiang T; Xie P; Liu H J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036 [TBL] [Abstract][Full Text] [Related]
3. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma. Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457 [TBL] [Abstract][Full Text] [Related]
4. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations. Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604 [TBL] [Abstract][Full Text] [Related]
5. Serum Annexin A2 Level Is Associated With Diagnosis and Prognosis in Patients With Oral Squamous Cell Carcinoma. Zhang W; Gao C; Zhang S; Fang G J Oral Maxillofac Surg; 2017 May; 75(5):1081-1087. PubMed ID: 27889534 [TBL] [Abstract][Full Text] [Related]
6. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma. Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475 [TBL] [Abstract][Full Text] [Related]
7. SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma. Shao T; Huang J; Zheng Z; Wu Q; Liu T; Lv X Cell Physiol Biochem; 2018; 47(1):26-38. PubMed ID: 29763905 [TBL] [Abstract][Full Text] [Related]
8. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma. Jiang T; Liu G; Wang L; Liu H PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma. Chen L; Hu J; Pan L; Yin X; Wang Q; Chen H Cancer Biomark; 2018; 23(3):333-339. PubMed ID: 30223386 [TBL] [Abstract][Full Text] [Related]
10. HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma. Sakata J; Hirosue A; Yoshida R; Kawahara K; Matsuoka Y; Yamamoto T; Nakamoto M; Hirayama M; Takahashi N; Nakamura T; Arita H; Nakashima H; Nagata M; Hiraki A; Shinohara M; Nakayama H Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109142 [TBL] [Abstract][Full Text] [Related]
11. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma. Yang Z; Liang X; Fu Y; Liu Y; Zheng L; Liu F; Li T; Yin X; Qiao X; Xu X EBioMedicine; 2019 Sep; 47():44-57. PubMed ID: 31409573 [TBL] [Abstract][Full Text] [Related]
12. Frequency of circulating CD14 Song Y; Zhou Q; Zhu H; Jing Y; Zhang X; Yang Y; Hu Q; Huang X; Ni Y J Oral Pathol Med; 2018 Nov; 47(10):923-929. PubMed ID: 29961993 [TBL] [Abstract][Full Text] [Related]
13. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Could Serve as a Potential Serological Biomarker for the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma. Xie J; Li Y; Kong J; Li C J Oral Maxillofac Surg; 2019 Apr; 77(4):859-866. PubMed ID: 30611690 [TBL] [Abstract][Full Text] [Related]
14. Serum circulating human mRNA profiling and its utility for oral cancer detection. Li Y; Elashoff D; Oh M; Sinha U; St John MA; Zhou X; Abemayor E; Wong DT J Clin Oncol; 2006 Apr; 24(11):1754-60. PubMed ID: 16505414 [TBL] [Abstract][Full Text] [Related]
15. Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma. Chang KP; Lin SJ; Liu SC; Yi JS; Chien KY; Chi LM; Kao HK; Liang Y; Lin YT; Chang YS; Yu JS Sci Rep; 2015 Jul; 5():11689. PubMed ID: 26138061 [TBL] [Abstract][Full Text] [Related]
16. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma. Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502 [TBL] [Abstract][Full Text] [Related]
17. Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma. Yang CZ; Ma J; Luo QQ; Neskey DM; Zhu DW; Liu Y; Myers JN; Zhang CP; Zhang ZY; Zhong LP J Oral Pathol Med; 2014 Jan; 43(1):28-34. PubMed ID: 23710769 [TBL] [Abstract][Full Text] [Related]
18. Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma. Ding L; Li B; Zhao Y; Fu YF; Hu EL; Hu QG; Ni YH; Hou YY Tumour Biol; 2014 Oct; 35(10):10539-46. PubMed ID: 25060177 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms. Foo WC; Jo VY; Krane JF Cancer Cytopathol; 2016 Jun; 124(6):397-405. PubMed ID: 26882287 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma. Lee LT; Wong YK; Hsiao HY; Wang YW; Chan MY; Chang KW Int J Oral Maxillofac Surg; 2018 Jun; 47(6):699-707. PubMed ID: 29174861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]